175 related articles for article (PubMed ID: 36165537)
21. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
Front Oncol; 2022; 12():927640. PubMed ID: 35936737
[TBL] [Abstract][Full Text] [Related]
22. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
Front Oncol; 2021; 11():635329. PubMed ID: 33928028
[TBL] [Abstract][Full Text] [Related]
23. The role of m6A RNA methylation in cancer.
Sun T; Wu R; Ming L
Biomed Pharmacother; 2019 Apr; 112():108613. PubMed ID: 30784918
[TBL] [Abstract][Full Text] [Related]
24. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
Maity A; Das B
FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
[TBL] [Abstract][Full Text] [Related]
25. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
Fang F; Wang X; Li Z; Ni K; Xiong C
Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
[TBL] [Abstract][Full Text] [Related]
27. The functions and clinical significance of circRNAs in hematological malignancies.
Zhou X; Zhan L; Huang K; Wang X
J Hematol Oncol; 2020 Oct; 13(1):138. PubMed ID: 33069241
[TBL] [Abstract][Full Text] [Related]
28. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
29. The role of N6-methyladenosine mRNA in the tumor microenvironment.
Li M; Zha X; Wang S
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188522. PubMed ID: 33545295
[TBL] [Abstract][Full Text] [Related]
30. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
Zhang Z; Wei W; Wang H; Dong J
Front Oncol; 2021; 11():743990. PubMed ID: 34722298
[TBL] [Abstract][Full Text] [Related]
31. Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate.
Xu Y; Liu J; Chen WJ; Ye QQ; Chen WT; Li CL; Wu HT
Front Cell Dev Biol; 2020; 8():561703. PubMed ID: 33072746
[TBL] [Abstract][Full Text] [Related]
32. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
[TBL] [Abstract][Full Text] [Related]
33. N6-methyladenosine functions and its role in skin cancer.
Ran Y; Yan Z; Jiang B; Liang P
Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
[TBL] [Abstract][Full Text] [Related]
34. N6-methyladenosine links RNA metabolism to cancer progression.
Dai D; Wang H; Zhu L; Jin H; Wang X
Cell Death Dis; 2018 Jan; 9(2):124. PubMed ID: 29374143
[TBL] [Abstract][Full Text] [Related]
35. Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression.
Zheng QK; Ma C; Ullah I; Hu K; Ma RJ; Zhang N; Sun ZG
Onco Targets Ther; 2021; 14():4837-4846. PubMed ID: 34556998
[TBL] [Abstract][Full Text] [Related]
36. Functions of RNA N
Zheng X; Gong Y
Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
[TBL] [Abstract][Full Text] [Related]
37. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
38. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
Liu Q
Front Genet; 2021; 12():825109. PubMed ID: 35087575
[TBL] [Abstract][Full Text] [Related]
39. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
Front Surg; 2022; 9():819335. PubMed ID: 35155557
[TBL] [Abstract][Full Text] [Related]
40. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
Barbarotto E; Calin GA
Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
